Serum Institute of India likely front-runner to win supply of HPV vaccines for UIP, says GlobalData
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
The facility will produce 150 million vaccine doses per year
Subscribe To Our Newsletter & Stay Updated